Tomáš Mrkvan

In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression

Kylie E. Webster, Stacey N. Walters, Rachel E. Kohler et al. · The Journal of Experimental Medicine · 2009 · 515 citations · Full text

Life Sciences, Cell Biology, Immunology +17

New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting

Petr Chytil, Tomáš Etrych, Čestmı́r Koňák et al. · Journal of Controlled Release · 2008 · 125 citations

Pharmacy, Oncology, Pharmaceutics +16

<i>N‐</i>(2‐hydroxypropyl)methacrylamide‐based polymer conjugates with pH‐controlled activation of doxorubicin. I. New synthesis, physicochemical characterization and preliminary biological evaluation

Tomáš Etrych, Tomáš Mrkvan, Petr Chytil et al. · Journal of Applied Polymer Science · 2008 · 114 citations

Pharmacy, Pharmaceutics, Pharmacology +13

In Vivo Expansion of Activated Naive CD8+ T Cells and NK Cells Driven by Complexes of IL-2 and Anti-IL-2 Monoclonal Antibody As Novel Approach of Cancer Immunotherapy

Jakub Tomala, Helena Chmelova, Tomáš Mrkvan et al. · The Journal of Immunology · 2009 · 100 citations

Life Sciences, Immunology, Oncology +14

Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting

Tomáš Etrych, Petr Chytil, Tomáš Mrkvan et al. · Journal of Controlled Release · 2008 · 98 citations

Pharmacy, Molecular Pharmaceutics, Pharmacology +14